Wellness products company Nature’s Sunshine Products (NASDAQ:NATR) will be reporting earnings tomorrow after market hours. Here's what to expect.

Nature's Sunshine missed analysts' revenue expectations by 1.9% last quarter, reporting revenues of $108.9 million, up 6% year on year. It was a mixed quarter for the company, with an impressive beat of analysts' earnings estimates.

Is Nature's Sunshine a buy or sell going into earnings? Read our full analysis here, it's free.

This quarter, analysts are expecting Nature's Sunshine's revenue to grow 2.4% year on year to $111.2 million, a reversal from the 1.7% decrease it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.17 per share.

The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Nature's Sunshine has only missed Wall Street's revenue estimates once over the last two years, exceeding top-line expectations by 4.5% on average.

Looking at Nature's Sunshine's peers in the personal care segment, some have already reported their Q1 results, giving us a hint as to what we can expect. USANA's revenues decreased 8.3% year on year, meeting analysts' expectations, and Medifast reported a revenue decline of 49.9%, in line with consensus estimates. USANA traded up 9.6% following the results while Medifast was down 22.5%.

Read our full analysis of USANA's results here and Medifast's results here.

Investors in the personal care segment have had steady hands going into earnings, with share prices flat over the last month. Nature's Sunshine is down 4% during the same time and is heading into earnings with an average analyst price target of $24 (compared to the current share price of $19.06).

When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we’ve found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback.